Target intelligence / Profile preview

RNA, U6 small nuclear 290, pseudogene (RNU6-290P)

Target
RNU6-290P
Molecular classification
Other (Pseudogene), Small nuclear RNA pseudogene
01

Overview

RNA, U6 small nuclear 290, pseudogene (RNU6-290P) is classified as a pseudogene of the U6 small nuclear RNA family. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they generally do not encode functional proteins or RNAs and do not participate in canonical biological processes such as catalysis, signaling, or direct molecular interactions. The canonical U6 small nuclear RNA (snRNA) is a core component of the spliceosome, involved in pre-mRNA splicing. However, RNU6-290P itself is a non-coding, non-functional relabeled genomic element believed to have arisen from retrotransposition or duplication of the active U6 gene, but lacking the elements necessary for normal expression and function. There is no current evidence that RNU6-290P serves as a therapeutic target, biomarker, or is implicated in disease processes. Its primary significance is as an annotated pseudogene in the genome. Its locus is located at chromosome 1q24.3. This gene entry is a pseudogene, not a functional protein, non-coding RNA, receptor, enzyme, or other conventional drug target class. It should not be treated as a therapeutic target, nor as a biomarker, unless future research indicates functional activity, which is currently lacking in all reputable databases and literature. If further clarification is needed on canonical U6 snRNA function, research should instead focus on U6 spliceosomal RNA, not pseudogene variants.

Other names
RNU6-290PLOC124901189
02

Biological functions

Other (No known biological function; pseudogene)
03

Disease associations

Other (No established direct disease association)

Beyond the preview

Go deeper on RNA, U6 small nuclear 290, pseudogene (RNU6-290P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 290, pseudogene (RNU6-290P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call